NOD2 and systemic lupus erythematosus: Moreover, NOD2 expression was decreased significantly in monocytes (Figure 1D, p = 0.047) and pDCs (Figure 1F, p = 0.012) in SLE patients with active disease despite on immunosuppressive treatment (Group 3) compared with those with inactive disease who were not receiving immunosuppressive treatment (Group 1).